Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38436
CAS Number:
14222-60-7
Prothionamide
Purity:
≥ 98 % (HPLC)
Synonym(s):
2-Propylpyridine-4-carbothioamide, 2-Propylthioisonicotinamide
Documents
$36.65 /5G
Taille
Request Bulk Quote
Informations sur le produit

Prothionamide is a potent thioamide compound primarily utilized in the treatment of tuberculosis, particularly in cases resistant to first-line therapies. This compound acts by inhibiting the synthesis of mycolic acids, essential components of the bacterial cell wall, thereby effectively combating Mycobacterium tuberculosis. Its unique mechanism of action makes it a valuable addition to multidrug regimens, especially for patients who have not responded to conventional treatments.

In addition to its therapeutic applications, Prothionamide is also of interest in research settings, where it is studied for its potential in developing new anti-tubercular agents. Its favorable pharmacokinetic properties, including good oral bioavailability and a manageable side effect profile, enhance its appeal in clinical settings. Researchers and healthcare professionals appreciate Prothionamide for its role in addressing the growing challenge of drug-resistant tuberculosis, making it a critical component in the ongoing fight against this global health issue.

Numéro CAS 
14222-60-7
Formule moléculaire
C9H12N2S
Poids moléculaire 
180.27
Point de fusion 
141 - 145 °C
Informations générales
Numéro CAS 
14222-60-7
Formule moléculaire
C9H12N2S
Poids moléculaire 
180.27
Point de fusion 
141 - 145 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Prothionamide is widely utilized in research focused on

  • Tuberculosis Treatment: This compound is primarily used as an anti-tubercular agent, particularly for treating multidrug-resistant tuberculosis. It enhances treatment options for patients who do not respond to standard therapies.
  • Pharmaceutical Development: Researchers are exploring prothionamide's efficacy in combination therapies, which can improve treatment outcomes and reduce the duration of therapy for various bacterial infections.
  • Drug Resistance Studies: Prothionamide serves as a valuable tool in studying mechanisms of drug resistance in Mycobacterium tuberculosis, helping scientists develop new strategies to combat resistant strains.
  • Research in Infectious Diseases: Its application extends to laboratory studies aimed at understanding the pharmacokinetics and pharmacodynamics of anti-tubercular drugs, providing insights into optimizing treatment regimens.
  • Public Health Initiatives: Prothionamide is critical in public health efforts to control tuberculosis outbreaks, especially in high-burden countries, by offering effective treatment alternatives.

Citations